XGN RSI Chart
Last 7 days
34.0%
Last 30 days
31.3%
Last 90 days
-11.7%
Trailing 12 Months
-41.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 55.7M | 0 | 0 | 0 |
2023 | 46.4M | 52.9M | 51.6M | 52.5M |
2022 | 48.1M | 42.9M | 45.4M | 45.6M |
2021 | 43.0M | 46.8M | 48.3M | 48.3M |
2020 | 40.7M | 39.2M | 39.5M | 42.0M |
2019 | 34.4M | 36.4M | 38.4M | 40.4M |
2018 | 0 | 0 | 0 | 32.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 04, 2024 | adawi kamal | sold | -24,406 | 1.90917 | -12,784 | cfo and corporate secretary |
Feb 29, 2024 | aballi john | acquired | 18,725 | 1.91 | 9,804 | president and ceo |
Feb 20, 2024 | adawi kamal | acquired | - | - | 75,000 | cfo and corporate secretary |
Feb 20, 2024 | aballi john | acquired | - | - | 175,000 | president and ceo |
Feb 06, 2024 | adawi kamal | sold | -13,133 | 1.9491 | -6,738 | cfo and corporate secretary |
Oct 17, 2023 | aballi john | sold | -59,017 | 1.7451 | -33,819 | president and ceo |
Aug 31, 2023 | aballi john | acquired | 20,998 | 2.142 | 9,803 | president and ceo |
Jun 15, 2023 | tullis james l l | bought | 519 | 3.1105 | 167 | - |
Mar 02, 2023 | adawi kamal | sold | -8,431 | 2.2993 | -3,667 | cfo and corporate secretary |
Mar 02, 2023 | hazeltine mark | sold | - | - | -3,667 | chief business officer |
Which funds bought or sold XGN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | STATE STREET CORP | reduced | -17.81 | -23,016 | 44,029 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | reduced | -65.08 | -29,751 | 11,512 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -83.76 | -1,000 | - | -% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | unchanged | - | -16,320 | 64,872 | -% |
May 15, 2024 | SILVERCREST ASSET MANAGEMENT GROUP LLC | unchanged | - | -217,951 | 866,354 | 0.01% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 1.04 | -9,057 | 37,937 | -% |
May 15, 2024 | Stonepine Capital Management, LLC | reduced | -42.57 | -721,157 | 611,514 | 0.48% |
May 15, 2024 | Nantahala Capital Management, LLC | reduced | -61.75 | -268,407 | 118,147 | 0.01% |
May 15, 2024 | RTW INVESTMENTS, LP | unchanged | - | -601,841 | 2,392,320 | 0.04% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -19.1 | -3,485 | 6,369 | -% |
Unveiling Exagen Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Exagen Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 196.9B | 23.7B | 44.73 | 8.29 | ||||
A | 45.2B | 6.7B | 36.57 | 6.71 | ||||
IDXX | 44.9B | 3.7B | 51.83 | 12.06 | ||||
DGX | 16.0B | 9.3B | 18.95 | 1.73 | ||||
NTRA | 13.1B | 1.2B | -35.76 | 10.81 | ||||
MEDP | 12.2B | 2.0B | 38.94 | 6.2 | ||||
CRL | 11.4B | 4.1B | 26.02 | 2.78 | ||||
EXAS | 9.3B | 2.5B | -38.69 | 3.67 | ||||
MID-CAP | ||||||||
GH | 3.1B | 603.7M | -6.73 | 5.14 | ||||
NEOG | 2.9B | 929.2M | 1.9K | 3.16 | ||||
SMALL-CAP | ||||||||
CDNA | 808.3M | 275.1M | -4.41 | 2.94 | ||||
ACRS | 84.8M | 31.1M | -1.1 | 2.73 | ||||
AWH | 33.0M | 9.2M | -2.24 | 3.6 | ||||
APDN | 2.5M | 5.5M | -0.2 | 0.45 | ||||
BIOC | 183.8K | 25.9M | -0.01 | 0.01 |
Exagen Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 4.7% | 14,415 | 13,765 | 13,416 | 14,137 | 11,230 | 12,837 | 14,726 | 7,606 | 10,394 | 12,689 | 12,251 | 12,772 | 10,587 | 12,668 | 10,775 | 8,948 | 9,584 | 10,214 | 10,439 | 10,474 | 9,260 |
Costs and Expenses | -7.9% | 17,418 | 18,912 | 18,485 | 19,052 | 18,936 | 27,328 | 22,543 | 21,670 | 20,073 | 18,943 | 18,755 | 18,514 | 16,154 | 15,429 | 14,561 | 12,365 | 14,805 | 13,072 | 12,596 | 12,884 | 11,134 |
S&GA Expenses | -13.7% | 10,542 | 12,216 | 11,375 | 11,953 | 11,884 | 12,812 | 14,151 | 12,903 | 12,152 | 11,802 | 11,528 | 11,171 | 10,040 | 9,929 | 9,202 | 8,276 | 9,626 | 7,915 | 7,306 | 7,302 | 6,179 |
R&D Expenses | -1.6% | 1,059 | 1,076 | 1,400 | 1,263 | 1,126 | 2,701 | 2,382 | 2,689 | 2,104 | 2,202 | 1,740 | 1,892 | 1,403 | 1,165 | 1,018 | 751 | 634 | 566 | 507 | 590 | 513 |
Interest Expenses | -3.0% | 549 | 566 | 557 | 574 | 638 | 626 | 618 | 606 | 598 | 639 | 678 | 663 | 645 | 652 | 647 | 635 | 631 | 771 | 909 | 910 | 901 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | 175 | - | - | - | 39.00 | - | - | -118 | 25.00 | - | - | - |
Net Income | 39.7% | -3,360 | -5,573 | -5,415 | -5,013 | -7,688 | -14,354 | -8,096 | -14,665 | -10,272 | -7,053 | -7,179 | -6,410 | -6,209 | -3,453 | -4,308 | -3,363 | -5,563 | -3,408 | -3,141 | -2,785 | -2,704 |
Net Income Margin | 22.9% | -0.35* | -0.45* | -0.63* | -0.66* | -0.97* | -1.04* | -0.88* | -0.91* | -0.64* | -0.56* | -0.48* | -0.44* | -0.40* | - | - | - | - | - | - | - | - |
Free Cashflow | -210.7% | -9,126 | 8,243 | -2,910 | -10,478 | -10,145 | -6,140 | -7,561 | -13,100 | -9,661 | -7,111 | -5,885 | -5,164 | -4,479 | - | - | - | - | - | - | - | - |
Balance Sheet | |||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2018Q4 |
Assets | -10.8% | 51.00 | 57.00 | 61.00 | 64.00 | 79.00 | 86.00 | 102 | 107 | 122 | 123 | 128 | 133 | 138 | 78.00 | 80.00 | 81.00 | 85.00 | 88.00 | 93.00 | 29.00 |
Current Assets | -11.4% | 42.00 | 48.00 | 49.00 | 51.00 | 66.00 | 73.00 | 82.00 | 88.00 | 104 | 113 | 118 | 125 | 129 | 71.00 | 73.00 | 73.00 | 78.00 | 81.00 | 86.00 | 21.00 |
Cash Equivalents | -24.7% | 27.00 | 36.00 | 28.00 | 31.00 | 52.00 | 62.00 | 69.00 | 76.00 | 90.00 | 100 | 107 | 113 | 118 | 58.00 | 62.00 | 64.00 | 69.00 | 72.00 | 78.00 | 13.00 |
Net PPE | - | - | - | - | - | - | - | - | - | - | 5.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 |
Goodwill | - | - | - | - | - | - | - | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
Liabilities | -10.0% | 31.00 | 34.00 | 33.00 | 32.00 | 43.00 | 44.00 | 45.00 | 44.00 | 46.00 | 39.00 | 37.00 | 37.00 | 36.00 | 37.00 | 36.00 | 33.00 | 34.00 | 33.00 | 34.00 | 36.00 |
Current Liabilities | -26.2% | 9.00 | 12.00 | 10.00 | 9.00 | 9.00 | 10.00 | 11.00 | 10.00 | 12.00 | 9.00 | 8.00 | 8.00 | 8.00 | 9.00 | 8.00 | 6.00 | 7.00 | 6.00 | 8.00 | 9.00 |
Long Term Debt | 0.2% | 19.00 | 19.00 | 19.00 | 19.00 | 29.00 | 29.00 | 28.00 | 28.00 | 28.00 | 27.00 | 27.00 | 27.00 | 27.00 | 27.00 | 26.00 | 26.00 | 26.00 | 26.00 | 26.00 | 25.00 |
LT Debt, Current | 1.5% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 19.00 | 19.00 | 19.00 | 29.00 | 29.00 | 28.00 | 28.00 | 28.00 | 27.00 | 27.00 | 27.00 | 27.00 | 27.00 | 26.00 | 26.00 | 26.00 | 26.00 | 26.00 | 25.00 |
Shareholder's Equity | -11.9% | 20.00 | 23.00 | 28.00 | 32.00 | 36.00 | 42.00 | 56.00 | 63.00 | 76.00 | 85.00 | 91.00 | 96.00 | 101 | 42.00 | 44.00 | 48.00 | 51.00 | 56.00 | 59.00 | - |
Retained Earnings | -1.2% | -282 | -279 | -273 | -268 | -263 | -255 | -241 | -233 | -218 | -208 | -201 | -193 | -187 | -181 | -177 | -173 | -170 | -164 | -161 | -152 |
Additional Paid-In Capital | 0.2% | 303 | 302 | 301 | 300 | 299 | 298 | 297 | 296 | 295 | 293 | 292 | 290 | 289 | 223 | 222 | 221 | 221 | 220 | 220 | 41.00 |
Shares Outstanding | 1.6% | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 16.00 | 16.00 | 15.00 | 13.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | 37.00 | - | - | - | 62.00 | - | - | - | 158 | - | - | - | 83.00 | - | - | 105 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -208.3% | -9,040 | 8,349 | -2,908 | -10,154 | -9,749 | -5,734 | -6,682 | -11,154 | -8,574 | -6,047 | -5,460 | -4,450 | -4,312 | -3,899 | -2,128 | -4,756 | -3,301 | -3,927 | -1,666 | -2,168 | -1,950 |
Share Based Compensation | -27.5% | 553 | 763 | 890 | 978 | 986 | 582 | 1,306 | 1,440 | 1,376 | 1,177 | 1,354 | 1,285 | 912 | 817 | 799 | 647 | 431 | 487 | 62.00 | 11.00 | 12.00 |
Cashflow From Investing | -2.4% | -86.00 | -84.00 | -2.00 | -322 | -396 | -406 | -879 | -1,946 | -1,087 | -1,064 | -475 | -714 | -167 | -5.00 | -213 | -153 | -84.00 | -26.00 | -2.00 | 288 | -363 |
Cashflow From Financing | 54.5% | -100 | -220 | -108 | -10,242 | -62.00 | -173 | -22.00 | -264 | -30.00 | -213 | 125 | -310 | 65,081 | -82.00 | 75.00 | -39.00 | -51.00 | -1,791 | 63,259 | 3,790 | 3,476 |
Unaudited Condensed Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 14,415 | $ 11,230 |
Operating expenses: | ||
Costs of revenue | 5,817 | 5,926 |
Selling, general and administrative expenses | 10,542 | 11,884 |
Research and development expenses | 1,059 | 1,126 |
Total operating expenses | 17,418 | 18,936 |
Loss from operations | (3,003) | (7,706) |
Interest expense | (549) | (638) |
Interest income | 192 | 656 |
Net loss | $ (3,360) | $ (7,688) |
Net loss per share, basic (in dollars per share) | $ (0.19) | $ (0.44) |
Net loss per share, diluted (in dollars per share) | $ (0.19) | $ (0.44) |
Weighted-average number of shares used to compute net loss per share, basic (in shares) | 17,944,438 | 17,526,763 |
Weighted-average number of shares used to compute net loss per share, diluted (in shares) | 17,944,438 | 17,526,763 |
Unaudited Condensed Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 27,267 | $ 36,493 |
Accounts receivable, net | 10,901 | 6,551 |
Prepaid expenses and other current assets | 4,232 | 4,797 |
Total current assets | 42,400 | 47,841 |
Property and equipment, net | 4,775 | 5,201 |
Operating lease right-of-use assets | 3,072 | 3,286 |
Other assets | 561 | 616 |
Total assets | 50,808 | 56,944 |
Current liabilities: | ||
Accounts payable | 1,470 | 3,131 |
Accrued and other current liabilities | 6,040 | 7,531 |
Operating lease liabilities | 1,005 | 976 |
Borrowings-current portion | 268 | 264 |
Total current liabilities | 8,783 | 11,902 |
Borrowings-non-current portion, net of discounts and debt issuance costs | 19,269 | 19,231 |
Non-current operating lease liabilities | 2,497 | 2,760 |
Other non-current liabilities | 268 | 357 |
Total liabilities | 30,817 | 34,250 |
Commitments and contingencies | ||
Stockholders' equity: | ||
Preferred stock, $0.001 par value per share; 10,000,000 shares authorized, no shares issued or outstanding as of March 31, 2024 and December 31, 2023 | 0 | 0 |
Common stock, $0.001 par value per share; 200,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 17,317,941 and 17,045,954 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 17 | 17 |
Additional paid-in capital | 302,550 | 301,893 |
Accumulated deficit | (282,576) | (279,216) |
Total stockholders' equity | 19,991 | 22,694 |
Total liabilities and stockholders' equity | $ 50,808 | $ 56,944 |